Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Subst Use Misuse 45:17421765 Rentzeperi E, Pegiou S, Koufakis T et al (2022) Sex differences in response to treatment with glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care
Maimoona Akhtar, orcid.org/0009-0002-1595-2023
It is associated with a reduction in visceral adipose tissue and liver fat, along with a slight proportional increase in subcutaneous fatty tissue in patients with obesity and diabetes, suggesting a degree of compartmental selectivity
Clinical implementation should consider patient-specific factors, including disease characteristics (etiology, location, progression), behavioral patterns (eg, exercise, sleep), and individual microbiota profiles, to guide the development of personalized diets, donor matching, targeted probiotics, and standardized metabolite formulations (eg, dosage forms, concentrations, and administration frequency)
We are dedicated to supporting your scientific endeavors by providing only the highest quality peptides
[1] [4] Whilst these medications are generally well-tolerated, some patients report experiencing hair thinning or increased shedding during treatment
